Screener
Capricor Therapeutics CAPR Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Capricor Therapeutics’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-060382
| Line item | March 31, 2026 / (unaudited) | December 31, 2025 | December 31, 2025 |
|---|---|---|---|
| TOTAL CURRENT ASSETS | 283,088,809 | 322,939,756 | |
| PROPERTY AND EQUIPMENT, net | 28,502,617 | 18,312,238 | |
| OTHER ASSETS | |||
| Lease right-of-use assets, net | 13,158,500 | 13,537,820 | |
| Other assets | 1,533,591 | 1,159,480 | |
| TOTAL ASSETS | $326,283,517 | $ | $355,949,294 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||
| CURRENT LIABILITIES |
Item 1. Financial Statements.
FAQ
- What is Capricor Therapeutics's operating lease ROU assets?
- Capricor Therapeutics (CAPR) reported operating lease ROU assets of $13.16M in Q1 2026.
- How has Capricor Therapeutics's operating lease ROU assets changed year-over-year?
- Capricor Therapeutics's operating lease ROU assets increased by 1066.8% year-over-year, from $1.13M to $13.16M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Capricor Therapeutics's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude